Vitamin D3 (Cholecalciferol) is a crucial vitamin that helps the body absorb calcium and phosphorus, which are vital for building and maintaining strong bones. It is often prescribed alongside calcium supplements and osteoporosis treatments to prevent bone loss and fractures.

Denosumab is a targeted biologic therapy (monoclonal antibody) administered via injection for the treatment of osteoporosis in postmenopausal women and men at high risk of fracture. It works differently from bisphosphonates by specifically targeting a protein to halt the formation and function of bone-resorbing cells.

Risedronate is a bisphosphonate used for the prevention and treatment of osteoporosis and Paget's disease of bone. It helps to strengthen bones, increase bone mineral density, and significantly reduce the risk of fractures by inhibiting the cells that break down bone tissue.

Alendronate is a bisphosphonate medication widely used to prevent and treat osteoporosis, particularly in postmenopausal women and older men. It works by slowing down bone loss, increasing bone density, and reducing the risk of bone fractures, including hip and spine fractures.